At a glance
- Originator Servier
- Class Anticoagulants; Antithrombotics
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 15 Sep 1999 New profile
- 15 Sep 1999 Preclinical development for Thrombosis in France (Unknown route)